Nanobiotix
NBTX
10 hedge funds and large institutions have $36.9M invested in Nanobiotix in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6.19% less ownership
Funds ownership: 19.73% → 13.54% (-6.2%)
17% less funds holding
Funds holding: 12 → 10 (-2)
21% less capital invested
Capital invested by funds: $46.5M → $36.9M (-$9.56M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$17.8K |
| 2 |
GI
GAMMA Investing
Foster City,
California
|
+$4.31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$14.3M |
| 2 |
BlackRock
New York
|
-$52.6K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.72K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$281 |
NBTX Hedge Fund Activity: Q3 2024 in Review
10 of the 6,981 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q3 2024, worth a combined $36.9M — down 21% from $46.5M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NBTX and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Citigroup, opening a new position worth an estimated $17.8K. The largest seller was Baillie Gifford & Co, exiting entirely with an estimated $14.3M sold.
- 10 institutional investors held Nanobiotix (NBTX) as of Q3 2024, down from 12 in Q2 2024.
- Funds reported $36.9M of Nanobiotix stock for Q3 2024, down 21% quarter-over-quarter.
- 1 fund opened new Nanobiotix positions in Q3 2024 and 3 closed out, a net change of -2 holders.
- The largest Nanobiotix buyer in Q3 2024 was Citigroup, an estimated $17.8K added.
- The largest Nanobiotix seller in Q3 2024 was Baillie Gifford & Co, an estimated $14.3M sold.
Based on aggregated 13F filings for Q3 2024.